Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,126–6,150 of 7,816 matching trials · page 246 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters NCT03408041 Medical file data extraction Runs in: Belgium · 1 site |
NA other |
COMPLETED | 129 | Murielle Surquin OTHER |
2018-01-23 |
|
Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride NCT00632645 Olanzapine; Xenazine; Tiapridal Runs in: France · 1 site |
PHASE3 other |
COMPLETED | 180 | Assistance Publique - Hôpitaux de Paris OTHER |
2018-01-19 |
|
Lacunar Intervention Trial 1 (LACI-1) NCT02481323 isosorbide mononitrate; cilostazol Runs in: United Kingdom · 2 sites |
PHASE2 other |
COMPLETED | 57 | University of Edinburgh OTHER |
2018-01-19 |
|
Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease NCT02991235 PRJ212; Placebo Runs in: Spain · 1 site |
NA other |
UNKNOWN | 30 | Bioiberica INDUSTRY |
2018-01-19 |
|
Community Based Music and Dance Movement Therapy Group for Older Adults With Dementia NCT03404050 Music and dance movement therapy Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 7 | Edge Hill University OTHER |
2018-01-19 |
|
Effects of Tai Chi on Cognition, I-ADLs, and HRQOL in Older People With MCI NCT03404765 Tai Chi Runs in: Hong Kong · 1 site |
NA other |
COMPLETED | 160 | Chinese University of Hong Kong OTHER |
2018-01-19 |
|
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia NCT02640729 Nelotanserin; Placebo Runs in: United States · 10 sites |
PHASE2 other |
COMPLETED | 30 | Axovant Sciences Ltd. INDUSTRY |
2018-01-18 |
|
The COACH Project: Combined Online Assistance for Caregiver Health NCT03123224 Combined Aerobic and Resistance Exercise + Caregiver Skills Trainin... Runs in: United States · 1 site |
NA other |
UNKNOWN | 200 | Palo Alto Veterans Institute for Research OTHER |
2018-01-18 |
|
Delirium in Persons With Dementia NCT01394328 Runs in: United States · 1 site |
NA other |
COMPLETED | 308 | Penn State University OTHER |
2018-01-16 |
|
Computerized Cognitive Intervention in the Oldest-Old NCT03397498 CogniFit™; Control-games Runs in: United States · 2 sites |
NA other |
COMPLETED | 69 | Icahn School of Medicine at Mount Sinai OTHER |
2018-01-12 |
|
Fornix and NbM as Targets of Stimulation In Alzheimer's Disease NCT03352739 DBS of the fornix, power on; DBS of the NbM, power on; DBS of the f... Runs in: China · 1 site |
NA other |
UNKNOWN | 30 | Xuanwu Hospital, Beijing OTHER |
2018-01-11 |
|
Management of Mild Cognitive Impairment Patients With Extra Virgin Olive Oil - MICOIL NCT03362996 Freshly-Pressed Extra Virgin Olive Oil; extra virgin olive oil; med... Runs in: Greece · 1 site |
PHASE2 other |
UNKNOWN | 150 | Greek Alzheimer's Association and Related Disorders OTHER |
2018-01-08 |
|
Staccato Loxapine in Agitation (Proof of Concept) NCT00369577 Inhaled Placebo; Inhaled Loxapine 5 mg; Inhaled Loxapine 10 mg Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 129 | Alexza Pharmaceuticals, Inc. UNKNOWN |
2018-01-02 |
|
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind NCT03024944 18F-THK-5351 Runs in: United States · 1 site |
PHASE2 other |
WITHDRAWN | 0 | Columbia University OTHER |
2017-12-29 |
|
The Model and Effect Assessment of Training General Practitioner for Dementia Early Recognition NCT02782000 lessons,long-term supervision and message; lessons,short-term super... |
NA other |
COMPLETED | 162 | Peking University Sixth Hospital OTHER |
2017-12-27 |
|
Emotion Recognition Training in Antisocial Violent Offenders With Psychopathic Traits NCT03382808 SEE Training; GAZE Training Runs in: Germany · 1 site |
NA other |
UNKNOWN | 80 | University Hospital Tuebingen OTHER |
2017-12-26 |
|
Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition NCT00704327 Runs in: United States · 1 site |
NA other |
TERMINATED | 170 | Lahey Clinic OTHER |
2017-12-21 |
|
Evaluate the Correlation of NIRS, ABI, Exercise, baPWV and Albuminuria With Peripheral Artery Occlusion Disease (PAD) and Other Atherosclerosis Outcomes NCT03378024 oscillometric (Omron Colin co) |
NA other |
UNKNOWN | 650 | Chang Gung Memorial Hospital OTHER |
2017-12-19 |
|
Narcolepsy Protect Against Alzheimer's Disease? NCT03378453 PET-scan18F-AV-45; PET-scan18F-AV-45 Runs in: France · 1 site |
NA other |
COMPLETED | 38 | University Hospital, Montpellier OTHER |
2017-12-19 |
|
Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms NCT03349320 |
NA symptomatic-cholinergic |
COMPLETED | 37 | Federal University of Minas Gerais OTHER |
2017-12-18 |
|
Protocol of Virtual Interactive Memory-Training Program NCT02462135 Virtual interactive memory training; Passive information activities Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 60 | Ministry of Science and Technology, Taiwan OTHER_GOV |
2017-12-15 |
|
An Examination of the Use of Electrophysiological Brain Monitoring to Direct the Treatment of Mild Cognitive Impairment NCT03375151 EEG based feedback; Standard practice based feedback; No feedback |
NA other |
UNKNOWN | 60 | Brainmarc Ltd. INDUSTRY |
2017-12-15 |
|
Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease NCT01806896 PF-02545920; Placebo; PF-02545920; Placebo Runs in: France · 1 site |
PHASE2 other |
COMPLETED | 37 | Pfizer INDUSTRY |
2017-12-14 |
|
Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD NCT01920672 Timed Planned Activity; Home Safety and Education Program Runs in: United States · 1 site |
NA other |
COMPLETED | 82 | Johns Hopkins University OTHER |
2017-12-12 |
|
A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease NCT00710684 SB-742457 15mg; SB-742457 35mg; Placebo; donepezil 5-10mg Runs in: Argentina; Australia; Canada; Chile; Czechia; Germany; It... · 102 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 682 | GlaxoSmithKline INDUSTRY |
2017-12-07 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial